Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1854 1
1891 1
1897 1
1907 1
1908 1
1909 1
1910 1
1911 1
1914 1
1924 1
1930 1
1945 2
1946 1
1947 2
1950 1
1951 3
1952 6
1953 3
1954 1
1955 2
1956 3
1957 4
1958 5
1959 8
1961 2
1962 2
1963 1
1964 3
1965 6
1966 8
1967 7
1968 4
1969 10
1970 12
1971 10
1972 8
1973 2
1974 7
1975 9
1976 7
1977 6
1978 10
1979 18
1980 9
1981 5
1982 12
1983 11
1984 11
1985 13
1986 13
1987 16
1988 10
1989 11
1990 21
1991 21
1992 17
1993 24
1994 24
1995 25
1996 19
1997 21
1998 18
1999 23
2000 21
2001 19
2002 33
2003 22
2004 35
2005 45
2006 44
2007 51
2008 34
2009 22
2010 35
2011 43
2012 55
2013 61
2014 67
2015 71
2016 77
2017 64
2018 86
2019 113
2020 117
2021 109
2022 103
2023 128
2024 101

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,874 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial.
Lafayette R, Kristensen J, Stone A, Floege J, Tesař V, Trimarchi H, Zhang H, Eren N, Paliege A, Reich HN, Rovin BH, Barratt J; NefIgArd trial investigators. Lafayette R, et al. Among authors: stone a. Lancet. 2023 Sep 9;402(10405):859-870. doi: 10.1016/S0140-6736(23)01554-4. Epub 2023 Aug 14. Lancet. 2023. PMID: 37591292 Clinical Trial.
Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy.
Barratt J, Lafayette R, Kristensen J, Stone A, Cattran D, Floege J, Tesar V, Trimarchi H, Zhang H, Eren N, Paliege A, Rovin BH; NefIgArd Trial Investigators. Barratt J, et al. Among authors: stone a. Kidney Int. 2023 Feb;103(2):391-402. doi: 10.1016/j.kint.2022.09.017. Epub 2022 Oct 19. Kidney Int. 2023. PMID: 36270561 Free article. Clinical Trial.
Ecological momentary assessment.
Shiffman S, Stone AA, Hufford MR. Shiffman S, et al. Among authors: stone aa. Annu Rev Clin Psychol. 2008;4:1-32. doi: 10.1146/annurev.clinpsy.3.022806.091415. Annu Rev Clin Psychol. 2008. PMID: 18509902 Review.
The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008.
Cella D, Riley W, Stone A, Rothrock N, Reeve B, Yount S, Amtmann D, Bode R, Buysse D, Choi S, Cook K, Devellis R, DeWalt D, Fries JF, Gershon R, Hahn EA, Lai JS, Pilkonis P, Revicki D, Rose M, Weinfurt K, Hays R; PROMIS Cooperative Group. Cella D, et al. Among authors: stone a. J Clin Epidemiol. 2010 Nov;63(11):1179-94. doi: 10.1016/j.jclinepi.2010.04.011. Epub 2010 Aug 4. J Clin Epidemiol. 2010. PMID: 20685078 Free PMC article.
In Response.
Stone AB, Wu CL, Grant MC. Stone AB, et al. Anesth Analg. 2018 Jul;127(1):319-320. doi: 10.1213/ANE.0000000000003404. Anesth Analg. 2018. PMID: 29757777 No abstract available.
AGEP from a dog bite treated with Ibuprofen.
Chaucer B, Stone A, Whelan D, Demanes A, Fischer JL. Chaucer B, et al. Among authors: stone a. Am J Emerg Med. 2018 Oct;36(10):1927.e1-1927.e2. doi: 10.1016/j.ajem.2018.06.065. Epub 2018 Jul 2. Am J Emerg Med. 2018. PMID: 30238914
1,874 results